nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextroamphetamine—Sudden death—Irinotecan—colon cancer	0.03	0.03	CcSEcCtD
Dextroamphetamine—Cardiomyopathy—Fluorouracil—colon cancer	0.0287	0.0287	CcSEcCtD
Dextroamphetamine—Sudden death—Fluorouracil—colon cancer	0.0287	0.0287	CcSEcCtD
Dextroamphetamine—Sudden death—Capecitabine—colon cancer	0.0201	0.0201	CcSEcCtD
Dextroamphetamine—Cardiomyopathy—Capecitabine—colon cancer	0.0201	0.0201	CcSEcCtD
Dextroamphetamine—Speech disorder—Irinotecan—colon cancer	0.0179	0.0179	CcSEcCtD
Dextroamphetamine—Accidental injury—Irinotecan—colon cancer	0.0174	0.0174	CcSEcCtD
Dextroamphetamine—Speech disorder—Fluorouracil—colon cancer	0.0171	0.0171	CcSEcCtD
Dextroamphetamine—Sudden death—Methotrexate—colon cancer	0.015	0.015	CcSEcCtD
Dextroamphetamine—Euphoric mood—Fluorouracil—colon cancer	0.0126	0.0126	CcSEcCtD
Dextroamphetamine—Injury—Irinotecan—colon cancer	0.0121	0.0121	CcSEcCtD
Dextroamphetamine—Cerebrovascular accident—Irinotecan—colon cancer	0.0114	0.0114	CcSEcCtD
Dextroamphetamine—Blood pressure increased—Capecitabine—colon cancer	0.0103	0.0103	CcSEcCtD
Dextroamphetamine—Irritability—Fluorouracil—colon cancer	0.0102	0.0102	CcSEcCtD
Dextroamphetamine—Erectile dysfunction—Vincristine—colon cancer	0.00911	0.00911	CcSEcCtD
Dextroamphetamine—Photosensitivity reaction—Vincristine—colon cancer	0.00903	0.00903	CcSEcCtD
Dextroamphetamine—Weight decreased—Vincristine—colon cancer	0.00895	0.00895	CcSEcCtD
Dextroamphetamine—Speech disorder—Methotrexate—colon cancer	0.0089	0.0089	CcSEcCtD
Dextroamphetamine—Depression—Vincristine—colon cancer	0.0088	0.0088	CcSEcCtD
Dextroamphetamine—Weight decreased—Irinotecan—colon cancer	0.00872	0.00872	CcSEcCtD
Dextroamphetamine—Acute coronary syndrome—Vincristine—colon cancer	0.0087	0.0087	CcSEcCtD
Dextroamphetamine—Myocardial infarction—Vincristine—colon cancer	0.00865	0.00865	CcSEcCtD
Dextroamphetamine—Acute coronary syndrome—Irinotecan—colon cancer	0.00847	0.00847	CcSEcCtD
Dextroamphetamine—Sweating—Vincristine—colon cancer	0.00846	0.00846	CcSEcCtD
Dextroamphetamine—Photosensitivity reaction—Fluorouracil—colon cancer	0.00842	0.00842	CcSEcCtD
Dextroamphetamine—Myocardial infarction—Irinotecan—colon cancer	0.00842	0.00842	CcSEcCtD
Dextroamphetamine—Sweating—Irinotecan—colon cancer	0.00824	0.00824	CcSEcCtD
Dextroamphetamine—Acute coronary syndrome—Fluorouracil—colon cancer	0.00811	0.00811	CcSEcCtD
Dextroamphetamine—Myocardial infarction—Fluorouracil—colon cancer	0.00807	0.00807	CcSEcCtD
Dextroamphetamine—Libido decreased—Capecitabine—colon cancer	0.00805	0.00805	CcSEcCtD
Dextroamphetamine—Urinary tract infection—Fluorouracil—colon cancer	0.008	0.008	CcSEcCtD
Dextroamphetamine—Cerebrovascular accident—Capecitabine—colon cancer	0.00761	0.00761	CcSEcCtD
Dextroamphetamine—Disturbance in sexual arousal—Capecitabine—colon cancer	0.0074	0.0074	CcSEcCtD
Dextroamphetamine—Irritability—Capecitabine—colon cancer	0.00712	0.00712	CcSEcCtD
Dextroamphetamine—Mood swings—Capecitabine—colon cancer	0.00707	0.00707	CcSEcCtD
Dextroamphetamine—Abdominal pain upper—Capecitabine—colon cancer	0.00681	0.00681	CcSEcCtD
Dextroamphetamine—Toxic epidermal necrolysis—Capecitabine—colon cancer	0.00672	0.00672	CcSEcCtD
Dextroamphetamine—Agitation—Vincristine—colon cancer	0.00633	0.00633	CcSEcCtD
Dextroamphetamine—Convulsion—Vincristine—colon cancer	0.00597	0.00597	CcSEcCtD
Dextroamphetamine—Hypertension—Vincristine—colon cancer	0.00595	0.00595	CcSEcCtD
Dextroamphetamine—Photosensitivity reaction—Capecitabine—colon cancer	0.00589	0.00589	CcSEcCtD
Dextroamphetamine—Weight decreased—Capecitabine—colon cancer	0.00583	0.00583	CcSEcCtD
Dextroamphetamine—Hypertension—Irinotecan—colon cancer	0.0058	0.0058	CcSEcCtD
Dextroamphetamine—Depression—Capecitabine—colon cancer	0.00573	0.00573	CcSEcCtD
Dextroamphetamine—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.0057	0.0057	CcSEcCtD
Dextroamphetamine—Acute coronary syndrome—Capecitabine—colon cancer	0.00567	0.00567	CcSEcCtD
Dextroamphetamine—Cerebrovascular accident—Methotrexate—colon cancer	0.00567	0.00567	CcSEcCtD
Dextroamphetamine—Myocardial infarction—Capecitabine—colon cancer	0.00564	0.00564	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Vincristine—colon cancer	0.00563	0.00563	CcSEcCtD
Dextroamphetamine—Infection—Vincristine—colon cancer	0.00559	0.00559	CcSEcCtD
Dextroamphetamine—Urinary tract infection—Capecitabine—colon cancer	0.00559	0.00559	CcSEcCtD
Dextroamphetamine—Convulsion—Fluorouracil—colon cancer	0.00557	0.00557	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Irinotecan—colon cancer	0.00548	0.00548	CcSEcCtD
Dextroamphetamine—Chest pain—Fluorouracil—colon cancer	0.00547	0.00547	CcSEcCtD
Dextroamphetamine—Infection—Irinotecan—colon cancer	0.00544	0.00544	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Vincristine—colon cancer	0.00544	0.00544	CcSEcCtD
Dextroamphetamine—Anorexia—Vincristine—colon cancer	0.00536	0.00536	CcSEcCtD
Dextroamphetamine—Irritability—Methotrexate—colon cancer	0.0053	0.0053	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Irinotecan—colon cancer	0.0053	0.0053	CcSEcCtD
Dextroamphetamine—Mood swings—Methotrexate—colon cancer	0.00526	0.00526	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Fluorouracil—colon cancer	0.00525	0.00525	CcSEcCtD
Dextroamphetamine—Anorexia—Irinotecan—colon cancer	0.00522	0.00522	CcSEcCtD
Dextroamphetamine—Infection—Fluorouracil—colon cancer	0.00521	0.00521	CcSEcCtD
Dextroamphetamine—Tachycardia—Fluorouracil—colon cancer	0.00512	0.00512	CcSEcCtD
Dextroamphetamine—Insomnia—Vincristine—colon cancer	0.00509	0.00509	CcSEcCtD
Dextroamphetamine—Anorexia—Fluorouracil—colon cancer	0.005	0.005	CcSEcCtD
Dextroamphetamine—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.005	0.005	CcSEcCtD
Dextroamphetamine—Insomnia—Irinotecan—colon cancer	0.00496	0.00496	CcSEcCtD
Dextroamphetamine—Decreased appetite—Vincristine—colon cancer	0.00489	0.00489	CcSEcCtD
Dextroamphetamine—Dyspnoea—Irinotecan—colon cancer	0.00488	0.00488	CcSEcCtD
Dextroamphetamine—Erythema multiforme—Capecitabine—colon cancer	0.00488	0.00488	CcSEcCtD
Dextroamphetamine—Somnolence—Irinotecan—colon cancer	0.00487	0.00487	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Vincristine—colon cancer	0.00486	0.00486	CcSEcCtD
Dextroamphetamine—Fatigue—Vincristine—colon cancer	0.00485	0.00485	CcSEcCtD
Dextroamphetamine—Dyspepsia—Irinotecan—colon cancer	0.00482	0.00482	CcSEcCtD
Dextroamphetamine—Constipation—Vincristine—colon cancer	0.00481	0.00481	CcSEcCtD
Dextroamphetamine—Decreased appetite—Irinotecan—colon cancer	0.00476	0.00476	CcSEcCtD
Dextroamphetamine—Insomnia—Fluorouracil—colon cancer	0.00475	0.00475	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Irinotecan—colon cancer	0.00473	0.00473	CcSEcCtD
Dextroamphetamine—Fatigue—Irinotecan—colon cancer	0.00472	0.00472	CcSEcCtD
Dextroamphetamine—Constipation—Irinotecan—colon cancer	0.00469	0.00469	CcSEcCtD
Dextroamphetamine—Dyspnoea—Fluorouracil—colon cancer	0.00468	0.00468	CcSEcCtD
Dextroamphetamine—Somnolence—Fluorouracil—colon cancer	0.00467	0.00467	CcSEcCtD
Dextroamphetamine—Dyspepsia—Fluorouracil—colon cancer	0.00462	0.00462	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Vincristine—colon cancer	0.0046	0.0046	CcSEcCtD
Dextroamphetamine—Decreased appetite—Fluorouracil—colon cancer	0.00456	0.00456	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00453	0.00453	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Irinotecan—colon cancer	0.00448	0.00448	CcSEcCtD
Dextroamphetamine—Body temperature increased—Vincristine—colon cancer	0.00445	0.00445	CcSEcCtD
Dextroamphetamine—Abdominal pain—Vincristine—colon cancer	0.00445	0.00445	CcSEcCtD
Dextroamphetamine—Erectile dysfunction—Methotrexate—colon cancer	0.00442	0.00442	CcSEcCtD
Dextroamphetamine—Photosensitivity reaction—Methotrexate—colon cancer	0.00438	0.00438	CcSEcCtD
Dextroamphetamine—Abdominal pain—Irinotecan—colon cancer	0.00433	0.00433	CcSEcCtD
Dextroamphetamine—Body temperature increased—Irinotecan—colon cancer	0.00433	0.00433	CcSEcCtD
Dextroamphetamine—Depression—Methotrexate—colon cancer	0.00427	0.00427	CcSEcCtD
Dextroamphetamine—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.00424	0.00424	CcSEcCtD
Dextroamphetamine—Tremor—Capecitabine—colon cancer	0.00421	0.00421	CcSEcCtD
Dextroamphetamine—Urticaria—Fluorouracil—colon cancer	0.00417	0.00417	CcSEcCtD
Dextroamphetamine—Body temperature increased—Fluorouracil—colon cancer	0.00415	0.00415	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Vincristine—colon cancer	0.00415	0.00415	CcSEcCtD
Dextroamphetamine—Sweating—Methotrexate—colon cancer	0.0041	0.0041	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Irinotecan—colon cancer	0.00404	0.00404	CcSEcCtD
Dextroamphetamine—Asthenia—Vincristine—colon cancer	0.00404	0.00404	CcSEcCtD
Dextroamphetamine—Palpitations—Capecitabine—colon cancer	0.00397	0.00397	CcSEcCtD
Dextroamphetamine—Asthenia—Irinotecan—colon cancer	0.00393	0.00393	CcSEcCtD
Dextroamphetamine—Hypertension—Capecitabine—colon cancer	0.00388	0.00388	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Fluorouracil—colon cancer	0.00387	0.00387	CcSEcCtD
Dextroamphetamine—Diarrhoea—Vincristine—colon cancer	0.00385	0.00385	CcSEcCtD
Dextroamphetamine—Chest pain—Capecitabine—colon cancer	0.00383	0.00383	CcSEcCtD
Dextroamphetamine—Anxiety—Capecitabine—colon cancer	0.00381	0.00381	CcSEcCtD
Dextroamphetamine—Diarrhoea—Irinotecan—colon cancer	0.00375	0.00375	CcSEcCtD
Dextroamphetamine—Dry mouth—Capecitabine—colon cancer	0.00374	0.00374	CcSEcCtD
Dextroamphetamine—Dizziness—Vincristine—colon cancer	0.00372	0.00372	CcSEcCtD
Dextroamphetamine—Infection—Capecitabine—colon cancer	0.00364	0.00364	CcSEcCtD
Dextroamphetamine—Erythema multiforme—Methotrexate—colon cancer	0.00363	0.00363	CcSEcCtD
Dextroamphetamine—Dizziness—Irinotecan—colon cancer	0.00362	0.00362	CcSEcCtD
Dextroamphetamine—Diarrhoea—Fluorouracil—colon cancer	0.00359	0.00359	CcSEcCtD
Dextroamphetamine—Tachycardia—Capecitabine—colon cancer	0.00358	0.00358	CcSEcCtD
Dextroamphetamine—Vomiting—Vincristine—colon cancer	0.00358	0.00358	CcSEcCtD
Dextroamphetamine—Rash—Vincristine—colon cancer	0.00355	0.00355	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Capecitabine—colon cancer	0.00355	0.00355	CcSEcCtD
Dextroamphetamine—Dermatitis—Vincristine—colon cancer	0.00354	0.00354	CcSEcCtD
Dextroamphetamine—Headache—Vincristine—colon cancer	0.00352	0.00352	CcSEcCtD
Dextroamphetamine—Anorexia—Capecitabine—colon cancer	0.0035	0.0035	CcSEcCtD
Dextroamphetamine—Vomiting—Irinotecan—colon cancer	0.00348	0.00348	CcSEcCtD
Dextroamphetamine—Dizziness—Fluorouracil—colon cancer	0.00347	0.00347	CcSEcCtD
Dextroamphetamine—Rash—Irinotecan—colon cancer	0.00345	0.00345	CcSEcCtD
Dextroamphetamine—Dermatitis—Irinotecan—colon cancer	0.00345	0.00345	CcSEcCtD
Dextroamphetamine—Headache—Irinotecan—colon cancer	0.00343	0.00343	CcSEcCtD
Dextroamphetamine—Nausea—Vincristine—colon cancer	0.00334	0.00334	CcSEcCtD
Dextroamphetamine—Vomiting—Fluorouracil—colon cancer	0.00334	0.00334	CcSEcCtD
Dextroamphetamine—Insomnia—Capecitabine—colon cancer	0.00332	0.00332	CcSEcCtD
Dextroamphetamine—Rash—Fluorouracil—colon cancer	0.00331	0.00331	CcSEcCtD
Dextroamphetamine—Dermatitis—Fluorouracil—colon cancer	0.00331	0.00331	CcSEcCtD
Dextroamphetamine—Headache—Fluorouracil—colon cancer	0.00329	0.00329	CcSEcCtD
Dextroamphetamine—Dyspnoea—Capecitabine—colon cancer	0.00327	0.00327	CcSEcCtD
Dextroamphetamine—Nausea—Irinotecan—colon cancer	0.00325	0.00325	CcSEcCtD
Dextroamphetamine—Dyspepsia—Capecitabine—colon cancer	0.00323	0.00323	CcSEcCtD
Dextroamphetamine—Decreased appetite—Capecitabine—colon cancer	0.00319	0.00319	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Capecitabine—colon cancer	0.00317	0.00317	CcSEcCtD
Dextroamphetamine—Fatigue—Capecitabine—colon cancer	0.00316	0.00316	CcSEcCtD
Dextroamphetamine—Constipation—Capecitabine—colon cancer	0.00314	0.00314	CcSEcCtD
Dextroamphetamine—Nausea—Fluorouracil—colon cancer	0.00312	0.00312	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Capecitabine—colon cancer	0.003	0.003	CcSEcCtD
Dextroamphetamine—Urticaria—Capecitabine—colon cancer	0.00291	0.00291	CcSEcCtD
Dextroamphetamine—Body temperature increased—Capecitabine—colon cancer	0.0029	0.0029	CcSEcCtD
Dextroamphetamine—Abdominal pain—Capecitabine—colon cancer	0.0029	0.0029	CcSEcCtD
Dextroamphetamine—Convulsion—Methotrexate—colon cancer	0.0029	0.0029	CcSEcCtD
Dextroamphetamine—Chest pain—Methotrexate—colon cancer	0.00285	0.00285	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Methotrexate—colon cancer	0.00273	0.00273	CcSEcCtD
Dextroamphetamine—Infection—Methotrexate—colon cancer	0.00271	0.00271	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Capecitabine—colon cancer	0.0027	0.0027	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Methotrexate—colon cancer	0.00264	0.00264	CcSEcCtD
Dextroamphetamine—Asthenia—Capecitabine—colon cancer	0.00263	0.00263	CcSEcCtD
Dextroamphetamine—Anorexia—Methotrexate—colon cancer	0.0026	0.0026	CcSEcCtD
Dextroamphetamine—Diarrhoea—Capecitabine—colon cancer	0.00251	0.00251	CcSEcCtD
Dextroamphetamine—Insomnia—Methotrexate—colon cancer	0.00247	0.00247	CcSEcCtD
Dextroamphetamine—Dyspnoea—Methotrexate—colon cancer	0.00243	0.00243	CcSEcCtD
Dextroamphetamine—Somnolence—Methotrexate—colon cancer	0.00243	0.00243	CcSEcCtD
Dextroamphetamine—Dizziness—Capecitabine—colon cancer	0.00242	0.00242	CcSEcCtD
Dextroamphetamine—Dyspepsia—Methotrexate—colon cancer	0.0024	0.0024	CcSEcCtD
Dextroamphetamine—Decreased appetite—Methotrexate—colon cancer	0.00237	0.00237	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Methotrexate—colon cancer	0.00236	0.00236	CcSEcCtD
Dextroamphetamine—Fatigue—Methotrexate—colon cancer	0.00235	0.00235	CcSEcCtD
Dextroamphetamine—Vomiting—Capecitabine—colon cancer	0.00233	0.00233	CcSEcCtD
Dextroamphetamine—Rash—Capecitabine—colon cancer	0.00231	0.00231	CcSEcCtD
Dextroamphetamine—Dermatitis—Capecitabine—colon cancer	0.00231	0.00231	CcSEcCtD
Dextroamphetamine—Headache—Capecitabine—colon cancer	0.0023	0.0023	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Methotrexate—colon cancer	0.00223	0.00223	CcSEcCtD
Dextroamphetamine—Nausea—Capecitabine—colon cancer	0.00218	0.00218	CcSEcCtD
Dextroamphetamine—Urticaria—Methotrexate—colon cancer	0.00217	0.00217	CcSEcCtD
Dextroamphetamine—Abdominal pain—Methotrexate—colon cancer	0.00216	0.00216	CcSEcCtD
Dextroamphetamine—Body temperature increased—Methotrexate—colon cancer	0.00216	0.00216	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Methotrexate—colon cancer	0.00201	0.00201	CcSEcCtD
Dextroamphetamine—Asthenia—Methotrexate—colon cancer	0.00196	0.00196	CcSEcCtD
Dextroamphetamine—Diarrhoea—Methotrexate—colon cancer	0.00187	0.00187	CcSEcCtD
Dextroamphetamine—Dizziness—Methotrexate—colon cancer	0.00181	0.00181	CcSEcCtD
Dextroamphetamine—Vomiting—Methotrexate—colon cancer	0.00174	0.00174	CcSEcCtD
Dextroamphetamine—Rash—Methotrexate—colon cancer	0.00172	0.00172	CcSEcCtD
Dextroamphetamine—Dermatitis—Methotrexate—colon cancer	0.00172	0.00172	CcSEcCtD
Dextroamphetamine—Headache—Methotrexate—colon cancer	0.00171	0.00171	CcSEcCtD
Dextroamphetamine—Nausea—Methotrexate—colon cancer	0.00162	0.00162	CcSEcCtD
